MedElevator Войти в исследования
← Поиск публикаций

DOI 10.64898/2026.08.06.743365

Медицинская библиотека · bioRxiv : the preprint server for biology · 2026

NAMPT activation uncovers a senescence-specific vulnerability and promotes healthy aging in combination with NAM.

Alcaraz Michael, Ramachandra Raghuveer, Arnold Rouven, Garcia-Teneche Marcos, Rajesh Adarsh, Haddadin Laurence, Taing Mey, Lei Xue, Gandhi Armin, Tzaridis Theophilos, Miller Karl, Proulx Jessica, Rad Amirhossein Nayeri, Davis Andrew, Liou Angela, Tanaka Hiroshi, Dutta Tumpa, Poritt Rebecca, Cracan Valentin, Loweth Colin, Olson Steven, Gardell Stephen J, Jackson Michael, Adams Peter D

СтатьяПрепринтПеревод в очереди

Аннотация

Aging is driven by multiple interacting processes, suggesting that effective strategies to promote healthy aging may require simultaneous targeting of more than one underlying mechanism. Here we identify a strategy that couples restoration of nicotinamide adenine dinucleotide (NAD+) homeostasis with selective targeting of senescent cells, two mechanistically linked features of aging. Senescent cells express elevated intracellular levels of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in the nicotinamide (NAM) salvage pathway for NAD+ biosynthesis. Despite increased NAMPT abundance, isotope-tracing studies revealed decreased NAD+ biosynthesis and consumption, indicating that elevated NAMPT abundance was not accompanied by a corresponding increase in NAD+ metabolic flux. Treatment with the NAMPT activator SBI-0802162 engaged the spare enzymatic capacity of NAMPT in senescent cells and produced a marked rise in intracellular NAD+ that, when sustained, disrupted their transcriptional program and selectively reduced the viability of senescent cells but not proliferating cells. In mice, SBI-0802162 reduced circulating NAM levels, suggesting that sustained NAMPT activation may be limited by substrate availability. This observation prompted the development of a combination approach using SBI-0802162 together with dietary NAM supplementation. Co-administration of SBI-0802162 and NAM robustly increased tissue NAD+, suppressed select age-associated inflammatory signatures and markers of cellular senescence in a tissue-specific manner. These molecular effects occurred alongside preserved physical performance in aged mice and reductions in food intake and body weight, which were observed whether SBI-0802162 was present in the chow or administered by oral gavage. Together, these findings establish a mechanistically integrated approach to target two convergent features of aging, NAD+ dysregulation and senescent cell accumulation, and support combined NAMPT activation and NAM supplementation as a strategy to promote healthy aging.

Для цитирования: Alcaraz Michael, Ramachandra Raghuveer, Arnold Rouven, Garcia-Teneche Marcos, Rajesh Adarsh, Haddadin Laurence, Taing Mey, Lei Xue, Gandhi Armin, Tzaridis Theophilos, Miller Karl, Proulx Jessica, Rad Amirhossein Nayeri, Davis Andrew, Liou Angela, Tanaka Hiroshi, Dutta Tumpa, Poritt Rebecca, Cracan Valentin, Loweth Colin, Olson Steven, Gardell Stephen J, Jackson Michael, Adams Peter D. NAMPT activation uncovers a senescence-specific vulnerability and promotes healthy aging in combination with NAM.. bioRxiv : the preprint server for biology. 2026. DOI: 10.64898/2026.08.06.743365.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.